KODIAK SCIENCES INC. Financing Cash Flow
KODIAK SCIENCES INC. (KOD) reported Financing Cash Flow of $3.58 million for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-13.
Financial Statements › Cash Flow › Financing Activities
us-gaap:NetCashProvidedByUsedInFinancingActivities · last filed 2026-08-13
- KODIAK SCIENCES INC. net cash provided by (used in) financing activities for the quarter ending 2026-06-30 was $2.96M, a 2369.17% increase year-over-year.
- KODIAK SCIENCES INC. net cash provided by (used in) financing activities for the quarter ending 2026-03-31 was $619.00K, a 399.19% increase year-over-year.
- KODIAK SCIENCES INC. net cash provided by (used in) financing activities for the quarter ending 2025-12-31 was $177.25M, a 43772.52% increase year-over-year.
- KODIAK SCIENCES INC. net cash provided by (used in) financing activities for the quarter ending 2025-09-30 was $813.00K.
- KODIAK SCIENCES INC. net cash provided by (used in) financing activities for fiscal 2025 was $178.30M, a 35489.22% increase from fiscal 2024.
- KODIAK SCIENCES INC. net cash provided by (used in) financing activities for fiscal 2024 was $501.00K, a 1516.13% increase from fiscal 2023.
- KODIAK SCIENCES INC. net cash provided by (used in) financing activities for fiscal 2023 was $31.00K, a 98.36% decline from fiscal 2022.
- KODIAK SCIENCES INC. net cash provided by (used in) financing activities for fiscal 2022 was $1.90M, a 76.84% decline from fiscal 2021.
| Period end | Net Cash Provided by (Used in) Financing Activities 3 month | Net Cash Provided by (Used in) Financing Activities 6 month | Net Cash Provided by (Used in) Financing Activities 9 month | Net Cash Provided by (Used in) Financing Activities 12 month |
|---|---|---|---|---|
| 2026-06-30 | $2.96M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-13 | $3.58M 10-Q · filed 2026-08-13 | $180.83M derived: sum of 3 quarters · filed 2026-08-13 | $181.64M derived: sum of 4 quarters · filed 2026-08-13 |
| 2026-03-31 | $619.00K 10-Q · filed 2026-05-07 | $177.86M derived: sum of 2 quarters · filed 2026-05-07 | $178.68M derived: sum of 3 quarters · filed 2026-05-07 | $178.80M derived: sum of 4 quarters · filed 2026-08-13 |
| 2025-12-31 | $177.25M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-31 | $178.06M derived: sum of 2 quarters · filed 2026-03-31 | $178.18M derived: sum of 3 quarters · filed 2026-08-13 | $178.30M 10-K · filed 2026-03-31 |
| 2025-09-30 | $813.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-13 | $933.00K derived: sum of 2 quarters · filed 2026-08-13 | $1.06M 10-Q · filed 2025-11-13 | $1.46M derived: sum of 4 quarters · filed 2026-08-13 |
| 2025-06-30 | $120.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-13 | $244.00K 10-Q · filed 2026-08-13 | $648.00K derived: sum of 3 quarters · filed 2026-08-13 | $648.00K derived: sum of 4 quarters · filed 2026-08-13 |
| 2025-03-31 | $124.00K 10-Q · filed 2026-05-07 | $528.00K derived: sum of 2 quarters · filed 2026-05-07 | $528.00K derived: sum of 3 quarters · filed 2026-05-07 | $587.00K derived: sum of 4 quarters · filed 2026-05-07 |
| 2024-12-31 | $404.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-31 | $404.00K derived: sum of 2 quarters · filed 2026-03-31 | $463.00K derived: sum of 3 quarters · filed 2026-03-31 | $501.00K 10-K · filed 2026-03-31 |
| 2024-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-13 | $59.00K derived: sum of 2 quarters · filed 2025-11-13 | $97.00K 10-Q · filed 2025-11-13 | -$27.00K derived: sum of 4 quarters · filed 2026-03-31 |
| 2024-06-30 | $59.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-13 | $97.00K 10-Q · filed 2025-08-13 | -$27.00K derived: sum of 3 quarters · filed 2026-03-31 | -$39.00K derived: sum of 4 quarters · filed 2026-03-31 |
| 2024-03-31 | $38.00K 10-Q · filed 2025-05-14 | -$86.00K derived: sum of 2 quarters · filed 2026-03-31 | -$98.00K derived: sum of 3 quarters · filed 2026-03-31 | $72.00K derived: sum of 4 quarters · filed 2026-03-31 |
| 2023-12-31 | -$124.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-31 | -$136.00K derived: sum of 2 quarters · filed 2026-03-31 | $34.00K derived: sum of 3 quarters · filed 2026-03-31 | $31.00K 10-K · filed 2026-03-31 |
| 2023-09-30 | -$12.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-14 | $158.00K derived: sum of 2 quarters · filed 2024-11-14 | $155.00K 10-Q · filed 2024-11-14 | $252.00K derived: sum of 4 quarters · filed 2025-03-27 |
| 2023-06-30 | $170.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-14 | $167.00K 10-Q · filed 2024-08-14 | $264.00K derived: sum of 3 quarters · filed 2025-03-27 | $342.00K derived: sum of 4 quarters · filed 2025-03-27 |
| 2023-03-31 | -$3.00K 10-Q · filed 2024-05-15 | $94.00K derived: sum of 2 quarters · filed 2025-03-27 | $172.00K derived: sum of 3 quarters · filed 2025-03-27 | $226.00K derived: sum of 4 quarters · filed 2025-03-27 |
| 2022-12-31 | $97.00K derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-27 | $175.00K derived: sum of 2 quarters · filed 2025-03-27 | $229.00K derived: sum of 3 quarters · filed 2025-03-27 | $1.90M 10-K · filed 2025-03-27 |
| 2022-09-30 | $78.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-14 | $132.00K derived: sum of 2 quarters · filed 2023-11-14 | $1.80M 10-Q · filed 2023-11-14 | $3.96M derived: sum of 4 quarters · filed 2024-03-28 |
| 2022-06-30 | $54.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-14 | $1.72M 10-Q · filed 2023-08-14 | $3.88M derived: sum of 3 quarters · filed 2024-03-28 | $5.91M derived: sum of 4 quarters · filed 2024-03-28 |
| 2022-03-31 | $1.67M 10-Q · filed 2023-05-15 | $3.82M derived: sum of 2 quarters · filed 2024-03-28 | $5.85M derived: sum of 3 quarters · filed 2024-03-28 | $8.38M derived: sum of 4 quarters · filed 2024-03-28 |
| 2021-12-31 | $2.16M derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-28 | $4.19M derived: sum of 2 quarters · filed 2024-03-28 | $6.71M derived: sum of 3 quarters · filed 2024-03-28 | $8.18M 10-K · filed 2024-03-28 |
| 2021-09-30 | $2.03M derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-09 | $4.55M derived: sum of 2 quarters · filed 2022-11-09 | $6.03M 10-Q · filed 2022-11-09 | $622.31M derived: sum of 4 quarters · filed 2023-03-28 |
| 2021-06-30 | $2.52M derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-09 | $3.99M 10-Q · filed 2022-08-09 | $620.27M derived: sum of 3 quarters · filed 2023-03-28 | $621.08M derived: sum of 4 quarters · filed 2023-03-28 |
| 2021-03-31 | $1.47M 10-Q · filed 2022-05-10 | $617.75M derived: sum of 2 quarters · filed 2023-03-28 | $618.56M derived: sum of 3 quarters · filed 2023-03-28 | $619.06M derived: sum of 4 quarters · filed 2023-03-28 |
| 2020-12-31 | $616.28M derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-28 | $617.09M derived: sum of 2 quarters · filed 2023-03-28 | $617.59M derived: sum of 3 quarters · filed 2023-03-28 | $717.38M 10-K · filed 2023-03-28 |
| 2020-09-30 | $804.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-09 | $1.31M derived: sum of 2 quarters · filed 2021-11-09 | $101.10M 10-Q · filed 2021-11-09 | $400.44M derived: sum of 4 quarters · filed 2022-03-01 |
| 2020-06-30 | $504.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-09 | $100.29M 10-Q · filed 2021-08-09 | $399.63M derived: sum of 3 quarters · filed 2022-03-01 | $399.92M derived: sum of 4 quarters · filed 2022-03-01 |
| 2020-03-31 | $99.79M 10-Q · filed 2021-05-10 | $399.13M derived: sum of 2 quarters · filed 2022-03-01 | $399.41M derived: sum of 3 quarters · filed 2022-03-01 | $399.43M derived: sum of 4 quarters · filed 2022-03-01 |
| 2019-12-31 | $299.34M derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-01 | $299.63M derived: sum of 2 quarters · filed 2022-03-01 | $299.64M derived: sum of 3 quarters · filed 2022-03-01 | $299.69M 10-K · filed 2022-03-01 |
| 2019-09-30 | $285.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-09 | $300.00K derived: sum of 2 quarters · filed 2020-11-09 | $347.00K 10-Q · filed 2020-11-09 | $85.88M derived: sum of 4 quarters · filed 2021-03-01 |
| 2019-06-30 | $15.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-10 | $62.00K 10-Q · filed 2020-08-10 | $85.59M derived: sum of 3 quarters · filed 2021-03-01 | $84.54M derived: sum of 4 quarters · filed 2021-03-01 |
| 2019-03-31 | $47.00K 10-Q · filed 2020-05-11 | $85.58M derived: sum of 2 quarters · filed 2021-03-01 | $84.53M derived: sum of 3 quarters · filed 2021-03-01 | $83.84M derived: sum of 4 quarters · filed 2021-03-01 |
| 2018-12-31 | $85.53M derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-01 | $84.48M derived: sum of 2 quarters · filed 2021-03-01 | $83.79M derived: sum of 3 quarters · filed 2021-03-01 | $116.47M 10-K · filed 2021-03-01 |
| 2018-09-30 | -$1.05M derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-12 | -$1.74M derived: sum of 2 quarters · filed 2019-11-12 | $30.94M 10-Q · filed 2019-11-12 | $30.89M derived: sum of 4 quarters · filed 2020-03-16 |
| 2018-06-30 | -$686.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-14 | $31.99M 10-Q · filed 2019-08-14 | $31.94M derived: sum of 3 quarters · filed 2020-03-16 | |
| 2018-03-31 | $32.68M 10-Q · filed 2019-05-15 | $32.63M derived: sum of 2 quarters · filed 2020-03-16 | ||
| 2017-12-31 | -$50.00K derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-16 | $9.64M 10-K · filed 2020-03-16 | ||
| 2017-09-30 | $9.69M 10-Q · filed 2018-11-16 | |||
| 2016-12-31 | -$120.00K 10-K · filed 2019-03-27 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| RECURSION PHARMACEUTICALS, INC. (RXRX) | United States | $2.080B | -3.78 |
| ADMA BIOLOGICS, INC. (ADMA) | United States | $2.131B | 11.16 |
| Vericel Corp (VCEL) | United States | $2.011B | 93.97 |
| BIOCRYST PHARMACEUTICALS INC (BCRX) | United States | $2.175B | -6.63 |
| Greenland Mines Ltd (GRML) | United States | $2.362B | |
| Vir Biotechnology, Inc. (VIR) | United States | $1.814B | -6.85 |
| NOVAVAX INC (NVAX) | United States | $1.748B | -6.26 |
| Hemab Therapeutics Holdings, Inc. (COAG) | United States | $1.672B | |
| Beam Therapeutics Inc. (BEAM) | United States | $2.549B | -41.51 |
| Immunocore Holdings plc (IMCR) | $1.613B | -90.43 |